These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1136569)

  • 1. [Dose-response relationship of subcutaneously administered Arwin in patients with chronic arterial blood circulation disorders].
    Ehrly AM
    Vasa; 1975; 4(2):161-7. PubMed ID: 1136569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative therapy of chronic arterial occlusive diseases using subcutaneous administration of the rheologically effective snake venom Arwin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():243-5. PubMed ID: 4450660
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences with arwin in combination with thrombolytic therapy].
    Keil-Kuri E; Hess H
    Verh Dtsch Ges Inn Med; 1974; 80():1470-2. PubMed ID: 4454460
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Therapeutic defibrination with Ancrod].
    Ehrly AM
    Dtsch Med Wochenschr; 1974 Jan; 99(3):112-3. PubMed ID: 4812781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic defibrination using snake venom (Arvin) in arterial circulation disorders].
    Ehringer H; Dudczak E; Lechner K; Widhalm F
    Verh Dtsch Ges Inn Med; 1972; 78():624-7. PubMed ID: 4677225
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long-term treatment using Arwin of patients with chronic peripheral arterial blood circulation disorders].
    Ehrly AM
    Subsid Med; 1974; 4():56-7. PubMed ID: 4548779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic defibrination with ancrod (author's transl)].
    Ehringer H; Dudczak R; Lechner K
    Dtsch Med Wochenschr; 1973 Nov; 98(48):2298-304. PubMed ID: 4797013
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improvement of blood viscosity through Arvin].
    Ehrly AM; Breddin K
    Verh Dtsch Ges Inn Med; 1972; 78():620-4. PubMed ID: 4677224
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of blood coagulation through Arwin].
    Vinazzer H
    Subsid Med; 1974; 4():53-5. PubMed ID: 4450561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of chronic peripheral arterial occlusive diseases with snake venom enzyme Arwin].
    Ehrly AM
    Med Welt; 1975 Mar; 26(10):446-55. PubMed ID: 1123988
    [No Abstract]   [Full Text] [Related]  

  • 11. Arwin in peripheral arterial circulatory disorders: controlled multicentre trials.
    Wolf GK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):387-92. PubMed ID: 786664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of defibrase on arterial thrombus formation.
    Bourgain RH; Six F
    Thromb Res; 1975 Feb; 6(2):195-200. PubMed ID: 1114485
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experience with Arwin (author's transl)].
    Hess H; Keil-Kuri E; Marshall M
    MMW Munch Med Wochenschr; 1975 Aug; 117(32-33):1317-20. PubMed ID: 819792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of flow properties of blood: a new principle for drug therapy of chronic peripheral arterial vascular disorders].
    Ehrly AM
    Vasa Suppl; 1973; 1():1-18. PubMed ID: 4517911
    [No Abstract]   [Full Text] [Related]  

  • 16. [Defibrination with the snake venom enzyme arwin in peripheral arterial obstructive disease. Possibilities and limitations (author's transl)].
    Böhme H; Schmidt P; Hüttel E
    MMW Munch Med Wochenschr; 1978 Nov; 120(45):1501-4. PubMed ID: 101819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic aspects in disorders of the microcirculation in peripheral arterial occlusive diseases].
    Ehrly AM
    Vasa; 1974; 3(3):312-8. PubMed ID: 4423612
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term results after defibrinogenation by Arwin in chronic occlusive arterial disease.
    Staiger J; Konrad-Graf S; Keil G
    Bibl Haematol; 1981; (47):252-7. PubMed ID: 7337665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modified dosage scheme for the subcutaneous use of arvin in patients with chronic arterial occlusive diseases].
    Ehrly AM; Köhler HJ
    Vasa; 1976; 5(2):155-62. PubMed ID: 973426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of microthrombi through arwin infusion in the rabbit].
    Müller-Berghaus G; Hocke M; Lasch HG
    Verh Dtsch Ges Inn Med; 1972; 78():1614-6. PubMed ID: 4665622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.